New funding for GHGSat’s expansion of satellites to detect methane emissions, USask’s VIDO receives a $6-million award for vaccine development from an international epidemic coalition, Ontario and Ottawa make investments in livestock research, and more.
Organization: Johnson & Johnson Innovation
Fusion raises US $25 million for cancer targeting technology
Fusion Pharmaceuticals Inc, a spin out of the Centre for Probe Development and Commercialization (CPDC), has secured US$25 million in series ‘A’ financing to support and accelerate development of new next-generation therapeutics that precisely target cancer cells.